NRx Pharmaceuticals, Inc.
NRXPNASDAQHealthcare● Active
$4.33
+$0.19(+4.59%)
Market Cap$74847142
P/E Ratio—
52W High$5.055
52W Low$1.62
NRx Pharmaceuticals, Inc.（NRXP）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · NRXP · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.23M | $0.00M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.51M | $0.01M | $0.01M | $0.00M | $0.00M |
| Gross Profit | $0.72M | ($0.01M) | ($0.01M) | ($0.00M) | ($0.00M) |
| Gross Margin %(computed) | 58.78% | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $3.78M | $6.20M | $13.37M | $17.03M | $20.26M |
| G&A Expenses | $13.06M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $16.94M | $19.70M | $27.58M | $44.33M | $95.20M |
| Operating Income | ($16.22M) | ($19.70M) | ($27.59M) | ($44.34M) | ($95.20M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.01M | $0.04M | $0.49M | $0.25M | $0.00M |
| Interest Expense | $0.67M | $1.08M | $0.12M | $0.00M | $0.02M |
| Income Before Tax | ($28.62M) | ($25.13M) | ($30.15M) | ($39.75M) | ($93.06M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($28.62M) | ($25.13M) | ($30.15M) | ($39.75M) | ($93.06M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.34 | $-2.39 | $-3.98 | $-0.60 | $-7.44 |
| Wtd Avg Shares | 21.40M | 10.52M | 7.58M | 65.77M | 46.92M |
| EBITDA | ($27.81M) | ($24.04M) | ($30.02M) | ($39.75M) | ($93.04M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解NRx Pharmaceuticals, Inc.
关于NRx Pharmaceuticals, Inc.（NRXP）损益表
NRx Pharmaceuticals, Inc.（NRXP）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，NRXP实现营收$0.00B，毛利润$0.00B（毛利率58.78%），净利润($0.03B)（净利率-2336.49%）。
常见问题
NRXP · 4 问NRx Pharmaceuticals, Inc.（NRXP）2025财年营收为$0.00B，同比up—%。
NRXP revenueNRXP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08